Endoglin/CD105 Rekombinanter Antikörper
Endoglin/CD105 Rekombinant Antikörper für WB, IHC, Indirect ELISA
Wirt / Isotyp
Kaninchen / IgG
Getestete Reaktivität
human
Anwendung
WB, IHC, Indirect ELISA
Konjugation
Unkonjugiert
CloneNo.
241196G9
Kat-Nr. : 82993-6-PBS
Synonyme
Geprüfte Anwendungen
Produktinformation
82993-6-PBS bindet in WB, IHC, Indirect ELISA Endoglin/CD105 und zeigt Reaktivität mit human
Getestete Reaktivität | human |
Wirt / Isotyp | Kaninchen / IgG |
Klonalität | Rekombinant |
Typ | Antikörper |
Immunogen | Rekombinantes Protein |
Vollständiger Name | endoglin |
Berechnetes Molekulargewicht | 71 kDa |
Beobachtetes Molekulargewicht | 75-90 kDa |
GenBank-Zugangsnummer | BC014271 |
Gene symbol | CD105 |
Gene ID (NCBI) | 2022 |
Konjugation | Unkonjugiert |
Form | Liquid |
Reinigungsmethode | Protein A purfication |
Lagerungspuffer | PBS only |
Lagerungsbedingungen | Store at -80°C. 20ul Größen enthalten 0,1% BSA. |
Hintergrundinformationen
Endoglin (ENG, CD105) is a homodimeric cell membrane glycoprotein of 180 kDa, composed of disulphide-linked subunits of 90-95 kDa. Endoglin is a proliferation-associated and hypoxia-inducible protein mainly expressed on vascular endothelial cells. It acts as an accessory receptor for transforming growth factor beta (TFG-β) and is involved in vascular development and remodelling. The important role of Endoglin in angiogenesis and in tumor progression makes it an ideal target for antiangiogenic therapy and a good marker for tumor prognosis. (PMID: 1326540; 14528280; 21737653; 12773481)